Podolsky D K, Lobb R, King N, Benjamin C D, Pepinsky B, Sehgal P, deBeaumont M
Gastrointestinal Unit, Massachusetts General Hospital, Boston 02114.
J Clin Invest. 1993 Jul;92(1):372-80. doi: 10.1172/JCI116575.
Recent studies have demonstrated the induced expression of endothelial adhesion molecules including E-selectin (also called endothelial leukocyte adhesion molecule-1), vascular cell adhesion molecule and intercellular adhesion molecule in actively involved mucosa of patients with ulcerative colitis and Crohn's disease. Similar induction has been demonstrated in the colon of the Cotton-top tamarin (CTT), a New World primate that experiences a spontaneous acute and chronic colitis resembling ulcerative colitis. To assess the potential importance of leukocyte adhesion as a necessary step in acute colitis, the effect of parenteral mAb directed against adhesion molecules on CTT colitis was evaluated in placebo-controlled blinded trials. Serial administration of either of two anti-E-selectin mAb designated BB11 and EH8 effectively coated endothelial surfaces expressing this vascular adhesion molecule. Although colitis activity was slightly diminished after the 10-d treatment period in CTT receiving either BB11 or EH8, this reduction was not significantly different than that seen in animals given a placebo control when assessed by a previously validated standardized scale of inflammatory activity: mean histologic activity grade 2.2 +/- 0.2 pretreatment vs 1.5 +/- 0.5 posttreatment in group receiving mAb and 2.1 +/- 0.1 pretreatment vs 1.3 +/- 0.5 posttreatment in the placebo group (P > 0.2). In contrast, administration of an anti-alpha 4 integrin mAb designated HP1/2 that binds VLA4 (alpha 4 beta 1) and presumably alpha 4 beta 7 integrins resulted in significant attenuation of acute colitis when compared to both pretreatment activity index (P = 0.005) and the placebo control group (P < 0.01): mean histologic activity grade 1.6 +/- 0.3 pretreatment vs 0.2 +/- 0.1 posttreatment in the group receiving HP1/2 and 1.8 +/- 0.5 pretreatment and 1.2 +/- 0.2 posttreatment in the placebo control group. These studies using a model of spontaneous colitis in the CTT demonstrate the feasibility of modulation of leukocyte-vascular adhesion and/or other integrin-mediated events possibly including T cell aggregation and T cell-stromal interactions, as well as lymphocyte homing. These results suggest both that these processes are important and possibly essential elements in sustaining acute colitis and that their disruption may result in therapeutic benefit.
最近的研究表明,在溃疡性结肠炎和克罗恩病患者的活动期黏膜中,内皮细胞黏附分子包括E-选择素(也称为内皮白细胞黏附分子-1)、血管细胞黏附分子和细胞间黏附分子会被诱导表达。在棉顶狨猴(CTT)的结肠中也发现了类似的诱导现象,CTT是一种新大陆灵长类动物,会经历类似于溃疡性结肠炎的自发性急性和慢性结肠炎。为了评估白细胞黏附作为急性结肠炎必要步骤的潜在重要性,在安慰剂对照的双盲试验中评估了针对黏附分子的静脉注射单克隆抗体对CTT结肠炎的影响。连续给予两种抗E-选择素单克隆抗体BB11和EH8中的任何一种,都能有效覆盖表达这种血管黏附分子的内皮表面。在接受BB11或EH8治疗10天后,CTT的结肠炎活动度略有降低,但与给予安慰剂对照的动物相比,这种降低并无显著差异,这是通过先前验证的标准化炎症活动量表评估得出的:接受单克隆抗体治疗组的平均组织学活动评分在治疗前为2.2±0.2,治疗后为1.5±0.5;安慰剂组在治疗前为2.1±0.1,治疗后为1.3±0.5(P>0.2)。相比之下,给予一种名为HP1/2的抗α4整合素单克隆抗体,它能结合VLA4(α4β1),可能还能结合α4β7整合素,与治疗前活动指数(P=0.005)和安慰剂对照组(P<0.01)相比,急性结肠炎得到了显著缓解:接受HP1/2治疗组的平均组织学活动评分在治疗前为1.6±0.3,治疗后为0.2±0.1;安慰剂对照组在治疗前为1.8±0.5,治疗后为1.2±0.2。这些使用CTT自发性结肠炎模型的研究表明,调节白细胞-血管黏附以及/或者其他整合素介导的事件(可能包括T细胞聚集和T细胞-基质相互作用以及淋巴细胞归巢)具有可行性。这些结果表明,这些过程在维持急性结肠炎中既是重要的,也可能是必不可少的因素,而且对它们的干扰可能会带来治疗益处。